This study reports a novel immune evasion strategy evolved by dengue virus (DENV) to dampen T-cell mediated viral clearance.

Background: While programmed death-ligand 1 (PD-L1)-targeted immunotherapy represents an advancement in non-small cell lung cancer (NSCLC), patient outcomes remain suboptimal. Aberrant activation of ...

Thank you for signing up! Did you know with a Digital Subscription to Belfast News Letter, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ...

This repository hosts multilspy, a library developed as part of research conducted for NeruIPS 2023 paper titled "Monitor-Guided Decoding of Code LMs with Static Analysis of Repository Context" ...

Google Cloud is moving forward with plans to launch its own layer-1 (L1) blockchain, positioning the network as neutral infrastructure for global finance at a time when fintech competitors are ...

The treatment of tumors remains one of the most challenging issues in modern medicine. For a long time, surgical intervention and radiochemotherapy were the primary methods employed to combat tumors; ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Therapeutic inhibition of programmed cell ...

Sacituzumab tirumotecan and tagitanlimab combination shows promising efficacy and safety as a first-line treatment for advanced NSCLC. Cohort 1B demonstrated a higher ORR of 66.7% with a more frequent ...